Cargando…
(188)Re-HEDP therapy in the therapy of painful bone metastases
For bone-targeted radionuclide therapy (BTRT), different commercial radiopharmaceuticals are available such as strontium-89, (186)Rhenium-hydroxyethylidene diphosphonate ((186)Re-HEDP), Samarium-153-ethylenediamine tetramethylene phosphonic acid, and radium-223. Unfortunately, the commercial availab...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034542/ https://www.ncbi.nlm.nih.gov/pubmed/30034275 http://dx.doi.org/10.4103/wjnm.WJNM_85_17 |